Navigation Links
Amphetamobile Develops AMMO RACK App for SciVerse Applications
Date:12/15/2011

AMSTERDAM, December 15, 2011 /PRNewswire/ --

Researchers to save and organize content for mobile use with document management app

Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced the availability of the AMMO RACK app on SciVerse Applications. Developed by mobile platform developer Amphetamobile (AMMO), the application enables users to save PDFs of interest in SciVerse for further organization and consumption on their mobile devices.

Using the AMMO RACK app, researchers can store SciVerse article PDFs to an online AMMO RACK cloud storage account and then direct these articles to a complementary document management app for the iPad, iPod or iPhone. Once downloaded to the AMMO RACK app, users can easily sort, assign, read and annotate their documents, whether online or offline.

"SciVerse Applications provides a unique opportunity for us to help researchers pull content deeper into their mobile workflows, providing them with the ability to not only store and view PDFs from SciVerse, but also organize and manage them along with other documents on their mobile devices," said SiNae Pitts, PhD, CEO of Amphetamobile. "AMMO RACK empowers users to access and consume the content they need more freely and keeps them informed and productive, even when they are offline and on the go."

"We are committed to partnering with organizations that leverage their expertise and technologies in order to develop innovative applications for enhancing the workflow experience of researchers," said Rafael Sidi, Vice President, Application Marketplace and Developer Network at Elsevier. "Our work with Amphetamobile is an excellent example of the meaningful collaboration that we continuously seek to foster within the scientific community."

SciVerse Applications and the Developer Network provide opportunities for researchers and librarians to collaborate with developers in creating and promoting new applications that improve research workflows. The Developer Network features a growing community of application developers that gain potential recognition, prestige and revenue through their contributions to SciVerse Applications.

 

About Amphetamobile

Amphetamobile (AMMO) is an innovative provider of web and mobile application design, development and consulting. AMMO specializes in mobile content delivery platforms for scholarly publishing, e-learning, and m-health, as well as custom app development. AMMO is led by subject matter expertise in scientific research and a drive for creating refined user interfaces and experiences. AMMO leverages published content through strategic partnerships with internationally recognized publishers and brands to create premium apps with high quality content, intuitive design, and the best possible user experience. Apple's iTunes staff and app users have identified AMMO apps as noteworthy, valuable, and high-powered. Learn more at http://www.amphetamobile.com

About the Elsevier SciVerse Suite

The SciVerse (http://www.sciverse.com) suite of search and discovery offerings provides the global research community access to a constantly expanding universe of content and solutions which can now be accessed in one platform. The suite currently includes SciVerse ScienceDirect (http://www.sciencedirect.com), the world's largest source of peer-reviewed content containing more than 10 million articles, and SciVerse Scopus (http://www.scopus.com), an abstract and citation database containing 41 million records, 70% with abstracts and nearly 19,500 titles from 5,000 publishers worldwide. The platform also includes SciVerse Hub beta (http://www.hub.sciverse.com), which enables researchers to perform a single search across all of the SciVerse content as well as targeted web content with results ranked by relevancy and without duplication. SciVerse Applications (http://www.applications.sciverse.com) and Developer Network (http://www.developers.sciverse.com) allow the scientific community to build, find and use applications that enhance the SciVerse research experience.

 

About Elsevier

Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions include SciVerse ScienceDirect, SciVerse Scopus, Reaxys, MD Consult and Nursing Consult, which enhance the productivity of science and health professionals, and the SciVal suite and MEDai's Pinpoint Review, which help research and health care institutions deliver better outcomes more cost-effectively.



A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC, a world-leading publisher and information provider, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

Media contact
Will DeGirolamo
+1-212-752-8338
wdegirolamo@psbpr.com



'/>"/>
SOURCE Elsevier
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Diplomat Specialty Pharmacy Develops and Launches Best-In-Class Electronic Navigator (eNAV(TM)) Patient Care System
2. Nventa Develops Proprietary Vaccine Adjuvant
3. Bad News to Bad Bugs: Northern Antibiotics Develops Novel Polymyxins With Reduced Toxicity
4. Siemens Corporate Research Develops RAPID2 System for Fast Discovery of Discriminative Pathogen Signatures
5. Binghamton Research Group Develops New Cancer Treatment
6. Saft Develops Super-Phosphate(TM) Technology for Rigorous Defense Applications
7. Panel of Osteoarthritis Experts Develops Optimal Profile of Exogenous Hyaluronic Acid
8. HDT Develops Robotic Arm Technology for DARPAs Revolutionizing Prosthetics 2009 Program
9. Solos Endoscopy, Inc. Develops Relay Lense Adapter System For MammoView® Product Line
10. PharmAthene Develops Thermostable Lyophilized rPA Anthrax Vaccine Under a Challenge Grant From the National Institutes of Health
11. Varian Medical Systems Develops New X-Ray Tube for Use in Security Scanning Systems
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... Texas , April 20, 2017  Vivify Health, ... mobile devices, has been awarded a very significant patent ... via EMRs to continual care via digital health.  This ... key intellectual property and further secures Vivify,s position as ... launched in 2009, was the first company to apply ...
(Date:4/20/2017)... WOONSOCKET, R.I. , April 20, 2017 /PRNewswire/ ... (NYSE: CVS), today unveiled a new store design ... new assortment of healthier food, health-focused products and ... the store to help customers discover new offerings. ... represent the next evolution of the customer experience ...
(Date:4/20/2017)... LUND, Sweden , April 20, 2017 /PRNewswire/ ... OTCQX: NEVPF) ("NeuroVive") today announced positive preclinical ... company,s preclinical compound for non-alcoholic steatohepatitis (NASH), ... NV556 has previously ... STAM™ NASH model. Today, NeuroVive,s scientists present ...
Breaking Medicine Technology:
(Date:4/28/2017)... ... April 28, 2017 , ... Ushio America ... lamps offer an instant energy-saving solution for F32T8 fluorescent lamps on most instant-start ... ballasts. These 50,000 hour rated lamps utilize the existing electronic ballast, saving labor ...
(Date:4/28/2017)... Manhattan New york (PRWEB) , ... April 28, ... ... is pleased to announce that Aditya Patel M.D. has joined the revolutionary endoscopic ... fellowship training and board certification in Interventional Pain Medicine. The patented, revolutionary eDiscSculpt ...
(Date:4/28/2017)... Edinburg, Texas (PRWEB) , ... April 28, 2017 , ... ... a plaque in recently to the labor and delivery team at Women’s Hospital at ... generous mothers who give birth at the hospital and decide to donate. , ...
(Date:4/28/2017)... ... April 28, 2017 , ... Early detection and elimination ... safety and minimize the cost of development. In this webinar, sponsored by Molecular ... lines and for cardiac toxicity using induced pluripotent stem cells (iPSCs). , In ...
(Date:4/28/2017)... ... 28, 2017 , ... Bill Howe started his sewer and drain company in ... Howe joined the team, the Bill Howe brand was born and they began cultivating ... giving back to the San Diego community in which they worked, lived and were ...
Breaking Medicine News(10 mins):